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Overexpression of JNK binding domain inhibited glu-
cose deprivation-induced JNK1 activation, relocaliza-
tion of Daxx from the nucleus to the cytoplasm, and
apoptosis signal-regulating kinase 1 (ASK1) oligomer-
ization in human prostate adenocarcinoma DU-145 cells.
However, SB203580, a p38 inhibitor, did not prevent re-
localization of Daxx and oligomerization of ASK1 during
glucose deprivation. Studies from in vivo labeling and
immune complex kinase assay demonstrated that phos-
phorylation of Daxx occurred during glucose depriva-
tion, and its phosphorylation was mediated through the
ASK1-SEK1-JNK1-HIPK1 signal transduction pathway.
Data from immunofluorescence staining and protein in-
teraction assay suggest that phosphorylated Daxx may
be translocated to the cytoplasm, bind to ASK1, and
subsequently lead to ASK1 oligomerization. Mutation of
Daxx Ser667 to Ala results in suppression of Daxx relo-
calization during glucose deprivation, suggesting that
Ser667 residue plays an important role in the relocaliza-
tion of Daxx. Unlike wild-type Daxx, a Daxx deletion
mutant (amino acids 501–625) mainly localized to the
cytoplasm, where it associated with ASK1, activated
JNK1, and induced ASK1 oligomerization without glu-
cose deprivation. Taken together, these results show
that glucose deprivation activates the ASK1-SEK1-
JNK1-HIPK1 pathway, and the activated HIPK1 is prob-
ably involved in the relocalization of Daxx from the
nucleus to the cytoplasm. The relocalized Daxx may play
an important role in glucose deprivation-induced ASK1
oligomerization.
We previously observed that glucose derivation increases the
intracellular levels of hydroperoxide and oxidized glutathione
(1). Our recent studies have shown that increases in steady-
state levels of hydrogen peroxide and glutathione disulfide are
sensed through thioredoxin (TRX)1 and glutaredoxin (GRX)
and subsequently activate the ASK1-MEK-MAPK signal trans-
duction pathway (2–4). TRX and GRX appear to act as physi-
ological inhibitors of ASK1 by associating with the N-terminal
and C-terminal portion of ASK1, respectively, and inhibiting
ASK1 kinase activity (2, 5). TRX and GRX contain two redox-
active half-cystine residues, -Cys-Gly-Pro-Cys- or -Cys-Pro-
Tyr-Cys-, in an active catalytic center (5–8). These sensor
molecules may be converted to the intramolecular disulfide
form of TRX-(S-S) and GRX-(S-S) during glucose deprivation.
The oxidized form of TRX and GRX dissociates from ASK1 and
consequently activates ASK1 (2, 3, 5). Recently, we observed
that release of TRX and GRX from ASK1 occurs with different
mechanisms: the glutathione-dependent GRX-ASK1 pathway
and the glutathione-independent TRX-ASK1 pathway (4). Dis-
sociation of either regulator from ASK1 is sufficient for ASK1
activation (4).
ASK1 is a member of the mitogen-activated protein kinase
kinase kinase family that activates the JNK and p38 pathways
by directly phosphorylating and thereby activating their re-
spective mitogen-activated protein kinase kinases, MKK4
(SEK1)/MKK7 and MKK3/MKK6 (9). ASK1 is activated by
oxidative stress (2, 5), TNF- (10, 11), Fas ligand (12, 13), and
endoplasmic reticulum stress (14). Previous studies have
shown that TNF- activates ASK1 via TRAF2, a member of the
TNF-receptor-associated factor (TRAF) family (10, 11),
whereas Fas ligand activates ASK1 via Daxx (12, 13). Liu et al.
(11) reported that TRAF2 activates ASK1 by enhancing and
stabilizing the oligomerization of ASK1. Chang et al. (12) ob-
served that Daxx activates ASK1 by displacing an inhibitory
intramolecular interaction between the NH2 and COOH ter-
mini of the kinase, thereby opening up the kinase into an active
conformation. Previous studies have also shown that ASK1 is
located in the cytoplasm and Daxx is mainly located in the
nucleus (13, 15). It is well known that Daxx relocalizes from the
nucleus to the cytoplasm in response to stress (15). Thus,
relocalization of Daxx is required prior to its interaction with
ASK1. A fundamental question is what molecular change(s)
regulate the relocalization of Daxx from the nucleus to the
cytoplasm in response to stress? Here we provide a possibility
that the initial activation of JNK1 during glucose deprivation
induces Daxx relocalization through phosphorylation. The re-
localized Daxx induces ASK1 oligomerization.
EXPERIMENTAL PROCEDURES
Cell Culture and Glucose Deprivation—Human prostate adenocarci-
noma (DU-145) cells were cultured in Dulbecco’s modified Eagle’s me-
dium with 10% fetal bovine serum (Invitrogen), and 26 mM sodium
bicarbonate for monolayer cell culture. The cells were maintained in a
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humidified atmosphere containing 5% CO2 and air at 37 °C. For glucose
deprivation, cells were rinsed three times with phosphate-buffered sa-
line (PBS) and then exposed to glucose-free Dulbecco’s modified Eagle’s
medium containing 10% dialyzed fetal bovine serum (Invitrogen).
Shuttle Vector Construction—pFLAG-CMV2-Daxx was kindly pro-
vided by Dr. Horikoshi (Mallinckrodt Institute of Radiology in Wash-
ington University, St. Louis, MO). pAdlox-FLAG-Daxx was made by
inserting the SpeI/BamHI fragment from pFLAG-CMV2-Daxx into
SpeI/BamHI-cut pAdlox shuttle vector (16). Various Daxx deletion mu-
tants FLAG-tagged at their N-terminal and restriction enzyme recog-
nition sites at the flanking sides (5, EcoRI; 3, BamHI) were produced
by PCR. For Daxx 1–625 (amino acids 1–625), sense primer was 5-
GAGCGAATTCAGCCACCGCTAACAGCATCATC-3 and antisense
primer was 5-CTGCGGATCCCTAACCAGAATCTCCCCAGTTGTG-3.
For Daxx 1–500 (amino acids 1–500), sense primer was the same as that
of Daxx 1–625, and antisense primer was 5-CTATGGATCCCTACTG-
TAGTGAGGACATGGGGCTC-3. For Daxx 501–625 (amino acids 501–
625), sense primer was 5-GCTCGAATTCAATCTCCAATG-AAAA-
GAACCTGG-3, and antisense primer was the same as that of Daxx
1–625. For Daxx 626–739 (amino acids 626–739), sense primer was
5-GGTTGAATTCACCCCCCTGCAAAAATCTCGG-3, and antisense
primer was 5-CTATGGATCCCTAATCAGAGTCTGAGAGCAC-3.
pcDNA3.1/His A-Daxx was made by inserting the PCR product of Daxx
digested with KpnI/EcoRI to KpnI/EcoRI-cut pcDNA3.1/His A. Sense
primer was CTGTGGTACCTGCCACCGCTAACAGCATCATC-3, and
antisense primer was 5-GACTGAATTCCTAATCAGAGTCTGAGAG-
CACG-3. pAdlox-His-Daxx was made by inserting SpeI/EcoRI frag-
ment from pcDNA3.1-His A-Daxx into SpeI/EcoRI-cut pAdlox.
pcDNA3-HA-ASK1 was kindly provided by Dr. Ichijo (Tokyo Medical
and Dental University, Tokyo, Japan). pAdlox-HA-ASK1 was made by
inserting the SpeI/XbaI fragment from pcDNA3-HA-ASK1 into XbaI-
cut pAdlox. pcDNA3-Myc-ASK1 was made by inserting the PCR prod-
uct of ASK1 to pcDNA3-Myc. Sense primer was 5-ATTATACGTATAG-
CACGGAGGCGGACGAGGG-3 introducing a SnaBI site, and
antisense primer was 5-CGCGTCTAGATCAAGTCTGTTTGTTTCGA-
AAGTCAATG-3 introducing a XbaI site for inserting into pcDNA3-Myc
(BamHI3 Klenow3 XbaI). pAdlox-Myc-ASK1 was made by inserting
the SpeI/XbaI fragment from pcDNA3-Myc-ASK1 into SpeI/XbaI-cut
pAdlox. pAdlox-FLAG-JBD was made by inserting the SpeI/XbaI frag-
ment from pcDNA3-FLAG-JBD into SpeI/XbaI-cut pAdlox. pAdlox-His-
JNK1 was also made by inserting the SpeI/XbaI fragment from
pcDNA3.1-His A-JNK1 into SpeI/XbaI-cut pAdlox.
Adenoviral Vector Construction—All recombinant adenoviruses were
constructed by employing the Cre-lox recombination system (16). The
selective cell line CRE8 has a -actin-based expression cassette driving
a Cre recombinase gene with an N-terminal nuclear localization signal
stably integrated into 293 cells. Transfections were done by using
LipofectAMINE Reagent (Invitrogen). 5  105 cells were split into a
6-well plate 1 day before transfection. For the production of recombi-
nant adenovirus, 2 g of SfiI/ApaI-digested Adlox/HA or Myc-ASK1
fragment or Adlox/FLAG-JBD or SfiI-digested Adlox/FLAG-Daxx in-
cluding various Daxx deletion mutants or His-Daxx fragment or Adlox/
His-JNK1 and 2 g of 5 viral genomic DNA were co-transfected into
CRE8 cells. The recombinant adenoviruses were generated by intermo-
lecular homologous recombination between the shuttle vector and 5
viral DNA. A new virus has an intact packaging site and carries a
recombinant gene. Plaques were harvested, analyzed, and purified. The
insertion of HA-ASK1 or Myc-ASK1 or FLAG-JBD or various FLAG-
Daxx or His-Daxx or His-JNK1 to adenovirus was confirmed by West-
ern blot analysis, after infection of corresponding recombinant adeno-
virus into DU-145 cells.
In Vivo Binding of ASK1 with Daxx—To examine the interaction
between ASK1 and Daxx, adenovirus of HA-tagged ASK1 (Ad.HA-
ASK1) and FLAG-tagged Daxx (Ad.FLAG-Daxx) at an MOI of 10 were
co-infected into DU-145 cells in 10-cm culture plates. For immunopre-
cipitation, after 48 h of infection, cells were lysed in buffer containing
150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 10 mM EDTA, 1% Triton X-100,
1% deoxycholate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 80 M
aprotinin, 2 mM leupeptin, and the lysates were incubated with 3 g of
anti-FLAG M2 mouse IgG1 (Sigma) or 0.5 g of rat anti-HA (clone
3F10; Roche Applied Science) for 2 h, respectively. After the addition of
protein G-agarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA),
the lysates were incubated for an additional 2 h. The beads were
washed three times with the lysis buffer, separated by SDS-PAGE, and
immunoblotted with rat anti-HA or mouse anti-HA (clone 12CA5; Roche
Applied Science) antibodies or mouse anti-FLAG. Proteins in the mem-
branes were then visualized using the ECL reagent as recommended by
the manufacturer (Amersham Biosciences).
Immune Complex Kinase Assay and in Vivo Labeling—The PCR
product of human Daxx having restriction enzyme sites at the flanking
sides (5, NdeI; 3, BamHI) was produced using the pFLAG/CMV2-Daxx
as a template. Sense primer was 5-GCTGCATATGGCCACCGCTAA-
CAGCATCATC-3, and antisense primer was 5-CTGCGGATCCCTA-
ATCAGAGTCTGAGAGCAC-3. pET15b/Daxx was made by inserting
NdeI/BamHI fragment from Daxx PCR product into NdeI/BamHI-cut
pET15b (Novagen, Madison, WI). pET15b/Daxx was transformed into
BL21(DE3)pLysS, and Daxx expression was confirmed by anti-Daxx
(Sigma). His-Daxx was purified by using His-bind column (Novagen).
For the immune complex kinase assay, DU-145 cells were infected with
Ad.His-JNK1 at an MOI of 10. After 48 h of infection, cells were in
glucose-free medium for 1 h and lysed in a buffer solution containing 20
mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1%
Triton X-100, 0.5% deoxycholate, 2 mM DTT, 1 mM sodium orthovana-
date, 1 mM PMSF, and protein inhibitor mixture solution (Sigma). Cell
extracts were clarified by centrifugation, and the supernatants were
immunoprecipitated with mouse anti-His antibody (Qiagen, Valencia,
CA) and protein G-agarose. The beads were washed twice with a solu-
tion containing 150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 5 mM EGTA, 2
mM DTT, 1 mM sodium orthovanadate, 1 mM PMSF, and protein inhib-
itor mixture solution and washed once with the kinase buffer solution,
and then they were subjected to kinase assays. To examine whether the
Daxx was a direct substrate of JNK1, 1 g of His-Daxx or GST-c-Jun
was incubated with immunoprecipitated His-JNK1 in kinase buffer
containing 20 mM Tris-HCl (pH 7.5), 20 mM MgCl2, 1 mM sodium
orthovanadate, 2 mM DTT, 20 M ATP, and 100 Ci/ml [-32P]ATP at
30 °C for 1 h. Finally, the reaction was stopped by adding 2 Laemmli
buffer. Phosphorylated proteins were resolved by SDS-PAGE and ana-
lyzed by autoradiography. For direct [32P]orthophosphate labeling of
His-Daxx, DU-145 cells were infected with Ad.His-Daxx at an MOI of
10. After 48 h of infection, cells were pre-equilibrated in phosphate-free
medium for 3 h prior to the addition of 50 Ci/ml of [32P]orthophosphate
(ICN, Irvine, CA) in phosphate and glucose-free medium for 1 h and
then lysed in a buffer solution containing 20 mM Tris-HCl (pH 7.5), 150
mM NaCl, 5 mM EGTA, 10 mM NaF, 1% Triton X-100, 0.5% deoxy-
cholate, 0.1% SDS, 2 mM DTT, 1 mM sodium orthovanadate, 1 mM
PMSF, and protein inhibitor mixture solution (Sigma). Cell extracts
were clarified by centrifugation, and the supernatants were immuno-
precipitated with mouse anti-His antibody and protein G-agarose. The
beads were washed three times with a solution containing 150 mM
NaCl, 20 mM Tris-HCl (pH 7.5), 5 mM EGTA, 2 mM DTT, 1 mM sodium
orthovanadate, 1 mM PMSF, and protein inhibitor mixture solution.
The immune complex was separated by SDS-PAGE, and dried gel was
visualized by autoradiography.
Immunoblot Analysis—Cell lysates were subjected to electrophoresis
on 10% polyacrylamide gels containing SDS under reducing conditions,
and the proteins in the gels were transferred onto a polyvinylidine
difluoride membrane. The membranes were incubated with 7% (w/v)
skim milk in PBST (PBS containing 0.1% (v/v) Tween 20) and then
reacted with primary antibodies. Polyclonal rabbit anti-ACTIVE JNK
was obtained from Promega (Madison, WI). Monoclonal mouse anti-
actin antibody was purchased from ICN. After washing three times
with PBST, the membranes were incubated with horseradish peroxi-
dase-conjugated anti-IgG. Then the proteins were detected with the
ECL reagent.
Immunofluorescence—Cellular localization of FLAG-Daxx (or His-
Daxx) was investigated using fluorescence microscopy. The cells were
plated onto a Lab-Tek chamber slide (Nalge Nunc, Naperville, IL) and
infected with Ad/FLAG-Daxx (or Ad/His-Daxx) at an MOI of 10. After
48 h of infection, cells were fixed in 100% cold methanol for 10 min at
20 °C. After washing twice with cold PBS, the cells were blocked in 1%
bovine serum albumin plus 10% rabbit or goat serum (depending on the
source of second antibody) for 1 h at room temperature. They were then
incubated with anti-FLAG (clone M2; mouse) or anti-His (penta-His;
mouse) antibodies containing 1% bovine serum albumin plus 10% rab-
bit or goat serum for 1 h at room temperature, followed by three washes
with cold PBS. Samples of FLAG-Daxx (or His-Daxx) were incubated for
1 h with fluorescein isothiocyanate-conjugated rabbit anti-mouse IgG.
After washing three times with cold PBS, the slides were mounted in
90% glycerol.
Production of HIPK1 Protein—To prepare HIPK1 substrate proteins
for kinase assay, a plasmid containing GST-HIPK1 was constructed in
the EcoRI/SmaI site of pGEX-4T-2 by inserting the BamHI/EcoRI frag-
ment from pcDNA3.1Myc.His-HIPK1 (kindly provided by P. Leder
(Howard Hughes Medical Institute, Boston, MA). pGEX-4T-2/HIPK1
was transformed into JM109, and HIPK1 expression was confirmed by
anti-HIPK1 antibody (kindly provided by P. Leder) and purified by
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using glutathione-Sepharose 4B (Amersham Biosciences).
Site-directed Mutagenesis—The QuikChangeTM site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA) was used to make point muta-
tions in Daxx protein. Two serine residues in Daxx (Ser667 and Ser670)
were replaced with alanine. Sense primer oligonucleotide (5-GTAC-
CCTGCCCGCCCCACCTTCCC-3) and antisense primer oligonucleo-
tide (5-GGGAAGGTGGGGCGGGCAGGGTAC-3) were for S667A.
Sense primer oligonucleotide (5-GCCCAGCCCACCTGCCCCCTTA-
GCTTC-3) and antisense primer oligonucleotide (5-GAAGCTAAGGG-
GGCAGGTGGGCTGGGC-3) were for S670A. PCR was prepared by
adding 5 l of 10 reaction buffer, 20 ng of double-stranded DNA
template (pFLAGCMV2-Daxx), 125 ng of each sense primer, 125 ng of
each antisense primer, 1 l of dNTP mix, double-distilled water to a
final volume of 50 l, and 1 l of Pfu Turbo DNA polymerase (2.5
units/l). PCR was performed with 12 cycles (95 °C for 30 s; 55 °C for 1
min; 68 °C for 14 min for S667A and 95 °C for 30 s; 58 °C for 1 min;
68 °C for 14 min for S670A) with an initial incubation at 95 °C for 30 s.
Following temperature cycling, the reaction was placed on ice for 2 min
to cool the reaction. After PCR, 1 l of DpnI restriction enzyme (10
units/l) was added directly to each amplification reaction and incu-
bated at 37 °C for 1 h to digest the parental supercoiled double-stranded
DNA. The DpnI-treated double-stranded DNA was transformed into
Epicurian Coli XL1-Blue supercompetent cells. Colonies were selected,
and each plasmid (pFLAGCMV2-Daxx) was subcloned into pAdlox-
Flag-Daxx, followed by digestion with HindIII/KpnI. Its fragment con-
taining the mutation site was subcloned into pBluescript SK(). Each
pBluescript SK()-Daxx fragment was sequenced using T7 primer to
confirm mutation.
RESULTS
Oligomerization of ASK1 and Interaction between Daxx and
ASK1 during Glucose Deprivation—Previous studies have
shown that oligomerization of ASK1 occurs during treatment
with TNF in human embryonic kidney 293 cells (11). Activation
of ASK1 requires reactive oxygen species-mediated dissociation
of TRX from ASK1 followed by the binding of TRAF2 and
consequent ASK1 homo-oligomerization (11). Thus, we exam-
ined whether Daxx also plays a role in the oligomerization of
ASK1 during glucose deprivation. Fig. 1A shows that homo-
oligomerization of ASK1 occurred during glucose deprivation or
H2O2 treatment. Unlike ASK1, Daxx existed as an oligomer
form irrespective of oxidative stress (Fig. 1B). Several research-
ers have shown that Daxx, a Fas-binding protein, binds to
ASK1, thereby activating the ASK1 kinase (12, 17). We inves-
tigated whether glucose deprivation induces interaction be-
tween Daxx and ASK1. Fig. 2 shows that Daxx associated with
ASK1 during oxidative stress (glucose deprivation or H2O2
treatment).
Daxx Binding Site to ASK1 and Localization of Various De-
letion Mutant Types of Daxx—We further examined which do-
main of Daxx is responsible for interacting with ASK1. Cells
were co-infected with Ad.HA-ASK1 and adenoviral vectors con-
taining wild-type Daxx or its various Daxx deletion mutants
(amino acids 1–625, 1–500, 501–625, and 626–739). Fig. 3A
shows that wild-type Daxx and Daxx deletion mutants (aa
1–625 and 501–625) interacted with ASK1 during glucose dep-
rivation. Fig. 3B shows that wild-type Daxx, which contains
two nuclear localization signals (18), is mainly located in the
nucleus. Wild-type Daxx relocalized to the cytoplasm during
glucose deprivation. In contrast, the Daxx deletion mutant (aa
501–625) is mainly located in the cytoplasm irrespective of the
extracellular glucose concentration. Other deletion mutants
(aa 1–625, 1–500, and 626–739), which contain one nuclear
localization signal, localize to both the cytoplasm and the nu-
cleus (Fig. 3B). Glucose deprivation did not significantly alter
the intracellular distribution of any of the deletion mutants
(Fig. 3B). These results suggest that intracellular location of
Daxx as well as amino acid residues of the Daxx domain play
an important role in the interaction between Daxx and ASK1.
This possibility was further examined. As shown previously in
Fig. 2, wild-type Daxx associated with ASK1 during glucose
deprivation (Fig. 4A, lane 3). However, unlike wild-type Daxx,
Daxx deletion mutant (aa 501–625) interacted with ASK1 re-
gardless of whether glucose was present or absent from the
medium (Fig. 4A, lanes 4 and 5). We also investigated whether
Daxx is involved in the homo-oligomerization of ASK1. Fig. 4B
FIG. 1. Oligomerization of ASK (A) or Daxx (B) during glucose
deprivation or H2O2 treatment in DU-145 cells. Cells were co-
infected with Ad.HA-ASK1 and Ad.Myc-ASK1 at an MOI of 10 (A) or
Ad.FLAG-Daxx and Ad.His-Daxx at an MOI of 10 (B). After 48 h of
infection, cells were exposed to glucose-free medium for 1 h or H2O2 (500
M) for 30 min. A, lysates were immunoprecipitated with anti-HA
antibody and immunoblotted with anti-Myc or anti-HA antibody (upper
panels). The presence of Myc-ASK1 in the lysates was verified by
immunoblotting with anti-Myc antibody (lower panel). B, lysates were
immunoprecipitated with anti-FLAG antibody and immunoblotted with
anti-His or anti-FLAG antibody (upper panels). The presence of His-
Daxx in the lysates was verified by immunoblotting with anti-His
antibody (lower panel). WB, Western blot; IP, immunoprecipitation.
FIG. 2. Interaction between Daxx and ASK1 during oxidative
stress. DU-145 cells were co-infected with Ad.HA-ASK1 at an MOI of
10, and adenoviral vectors containing FLAG-tagged Daxx (Ad.FLAG-
Daxx) at an MOI of 10. After 48 h of infection, cells were exposed to
glucose-free medium for 1 h or 500 M of H2O2 30 min. Lysates were
immunoprecipitated with anti-HA antibody and immunoblotted with
anti-FLAG or anti-HA antibody (top panels). The presence of FLAG-
Daxx in the lysates was verified by immunoblotting with anti-FLAG
antibody (bottom panel). WB, Western blot; IP, immunoprecipitation.
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shows that oligomerization of ASK1 induced by glucose depri-
vation was unaffected by overexpressed wild-type Daxx (Fig.
4B, lanes 3 and 5). Unlike wild type Daxx, expression of Daxx
deletion mutant (aa 501–625) caused oligomerization of ASK1
even in the presence of glucose (Fig. 4B, lane 6). The differen-
tial roles of wild-type Daxx and deletion mutant-type Daxx (aa
501–625) can be explained by differential localization of these
proteins (Fig. 3B). Previous studies have shown that Daxx
deletion mutant (aa 501–625) is largely responsible for JNK
activation (17). Fig. 4C shows that overexpression of Daxx
deletion mutant (aa 501–625) indeed activates JNK1 even in
the presence of glucose. These results suggest that physical
interaction between Daxx and ASK1 is sufficient to cause
ASK1 oligomerization and subsequent JNK1 activation.
Effect of JBD Overexpression on Relocalization of Daxx and
Interaction between ASK1 and Daxx during Glucose Depriva-
tion—A fundamental question that remains unanswered in
this study is how Daxx translocates to the cytoplasm during
glucose deprivation. One possibility is that oxidative stress-
induced ASK1-SEK1-JNK1 signal transduction is involved in
the relocalization of Daxx. We hypothesized that the ASK1-
SEK1-JNK1 pathway must already be activated to get in-
creased Daxx binding to ASK1, and then increased Daxx bind-
ing would maintain the activated ASK1-SEK1-JNK1. To test
this possibility, we overexpressed the JNK binding domain
(JBD), a negative regulator of JNK. As shown in Fig. 5, over-
expression of JBD inhibited JNK1 activation during glucose
deprivation. In contrast, JBD overexpression did not affect the
activation of p38 during glucose deprivation (data not shown).
Overexpression of JBD prevented relocalization of Daxx to the
cytoplasm and the binding of Daxx to ASK1 during glucose
deprivation or H2O2 treatment (Fig. 6, A, B, and D). However,
Daxx relocalization and interaction between Daxx and ASK1
were not prevented by treatment with SB203580, a specific p38
inhibitor (Fig. 6, C and D). We confirmed the inhibitory effect of
SB203580 on p38 by using a p38 MAP kinase assay kit (Cell
Signaling Technology, Inc., Beverly, MA) (data not shown). Our
results suggest that the oxidative stress-activated ASK1-
SEK1-JNK1 signal transduction pathway, but not the ASK1-
MKK3/MKK6-p38 pathway, plays an important role in the
relocalization of Daxx to the cytoplasm and its subsequent
interaction with ASK1.
Glucose Deprivation-induced Daxx Phosphorylation and Ef-
fect of JBD Overexpression on Daxx Phosphorylation—To in-
vestigate whether Daxx is phosphorylated during glucose dep-
rivation, DU-145 cells were infected with Ad.His-Daxx. Studies
from in vivo labeling with [32P]orthophosphate show that Daxx
was phosphorylated during glucose deprivation (Fig. 7, lane 3).
The phosphorylation of Daxx was suppressed by overexpres-
sion of JBD, a negative regulator of JNK (Fig. 7, lane 4). These
results suggest that JNK1 is involved in Daxx phosphorylation.
Phosphorylation of Daxx in the ASK1-SEK1-JNK1-HIPK1
Signal Transduction Pathway Is Mediated during Glucose Dep-
rivation—It is well known that activated JNK can phosphoryl-
FIG. 3. Effect of deletion mutant-
type Daxx on interaction between
Daxx and ASK1 and localization of
Daxx. A, cells were co-infected with
Ad.HA-ASK1 and adenoviral vectors con-
taining FLAG-tagged wild-type Daxx
(WT) or various deletion mutant types of
Daxx (amino acids 1–625, 1–500, 501–
625, or 626–739) at an MOI of 10. After
48 h of infection, cells were exposed to
complete medium or glucose-free medium
for 1 h. Lysates were immunoprecipitated
with anti-FLAG or mock antibody and im-
munoblotted with anti-HA antibody (up-
per panel). The presence of HA-ASK1 or
FLAG-Daxx in the lysates was verified by
immunoblotting with anti-HA or anti-
FLAG antibody (lower panels). B, cells
were infected with Ad.FLAG-Daxx (wild-
type or various deletion mutant-types of
Daxx) at an MOI of 10. After 48 h of
infection, cells were exposed to complete
medium or glucose-free medium for 1 h.
The subcellular localization of Daxx was
determined by immunofluorescent stain-
ing with anti-FLAG antibody (upper pan-
els). A schematic diagram of Daxx is
shown (lower panel). WB, Western blot;
IP, immunoprecipitation.
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ate various kinds of transcription factors such as ATF2 (19),
c-Jun (20), Elk1 (21), Sap1 (22), and p53 (23). Thus, we exam-
ined whether JNK1 directly phosphorylates Daxx. Fig. 8A
shows that activated JNK1 directly phosphorylated c-Jun but
not Daxx. These results suggest that activated JNK1 is indi-
rectly involved in Daxx phosphorylation. Recent studies show
that homeodomain-interacting protein kinase (HIPK1) physi-
cally interacts and directly phosphorylates Daxx (24). We hy-
pothesized that JNK1 activates HIPK1, which then conse-
quently phosphorylates Daxx. An immune complex kinase
assay indeed demonstrated that activated JNK1 directly phos-
phorylated HIPK1 (Fig. 8B) and consequently phosphorylated
Daxx (Fig. 8C). These results suggest that glucose deprivation-
induced Daxx phosphorylation is mediated through the JNK1-
HIPK1 signal transduction pathway.
Role of Serine Residue in the Relocalization of Daxx during
Glucose Deprivation—Ecsedy et al. (24) reported that HIPK1
phosphorylates murine Daxx on Ser669, and this amino acid
residue plays an important role in the relocalization of Daxx.
Unlike murine Daxx, human Daxx contains two serine residues
in positions 667 and 670. Based on previous results, we postu-
lated that either serine residue of Daxx plays a role in its
relocalization during glucose deprivation. To identify the serine
residue that plays an important role in the relocalization of
Daxx, we employed site-directed mutagenesis techniques to
create one point mutant at two serine residues (Ser3 Ala) and
evaluated its role in the relocalization of Daxx during glucose
deprivation. Fig. 9 shows that S667A mutant type Daxx, but
not S670A mutant type Daxx, did not relocalize to the cyto-
plasm during glucose deprivation.
Effect of JBD Overexpression on ASK1 Oligomerization dur-
ing Glucose Deprivation—We further investigated the effect of
JBD overexpression on ASK1 oligomerization. Fig. 10 shows
that glucose deprivation-induced ASK1 oligomerization was
inhibited by JBD overexpression (Fig. 10, lane 3 versus lane 5).
In contrast, Daxx deletion mutant (aa 501–625)-induced ASK1
oligomerization was not affected by JBD overexpression, re-
gardless of whether glucose was present or absent from the
medium. These results suggest that Daxx relocalization is essential
for the ASK1 oligomerization during glucose deprivation.
Model for the Role of the ASK1-MAPK-MEK Signal Trans-
duction in Daxx Trafficking during Glucose Deprivation—Fig.
11 shows a schematic diagram of a theoretical model based on
the literature and data presented here. According to the model,
glucose deprivation elevates the intracellular level of reactive
oxygen species, in particular H2O2. Reactive oxygen species
activate the ASK1-SEK1-JNK1-HIPK1 signaling pathway,
which subsequently signals the relocalization of Daxx from the
nucleus to the cytoplasm. The relocalization of Daxx may re-
quire its phosphorylation on Ser667 through activated HIPK1.
The cytoplasmic Daxx then binds to ASK1 and leads to ASK1
oligomerization.
FIG. 4. Effect of 501–625 deletion mutant-type Daxx on inter-
action between Daxx and ASK1, oligomerization of ASK1, and
JNK1 activation in DU-145 cells. A, cells were co-infected with
Ad.HA-ASK1 and adenoviral vectors containing FLAG-tagged wild-
type Daxx (WT) or 501–625 deletion mutant-type Daxx at an MOI of 10.
After 48 h of infection, cells were exposed to complete medium or
glucose-free medium for 1 h. Lysates were immunoprecipitated with
anti-FLAG, and immunoblotted with anti-HA antibody (upper panel).
The presence of HA-ASK1 or FLAG-Daxx in the lysates was verified by
immunoblotting with anti-HA or anti-FLAG antibody (lower panels). B,
cells were co-infected with Ad.HA-ASK1 and Ad.Myc-ASK1 at an MOI
of 10 and then Ad.FLAG-Daxx (either wild-type Daxx or deletion mu-
tant-type Daxx (aa 501–625) or Ad.EGFP at an MOI of 10. After 48 h of
infection, cells were exposed to complete medium or glucose-free me-
dium for 1 h. Lysates were immunoprecipitated with anti-HA antibody
and immunoblotted with anti-Myc or anti-HA antibody (upper panels).
The presence of Myc-ASK1 or FLAG-Daxx in the lysates was verified by
immunoblotting with anti-Myc or anti-FLAG antibody (lower panels).
C, cells were infected with either Ad.EGFP or Ad.FLAG-Daxx (wild-
type or various mutant types of Daxx) at an MOI of 10. After 48 h of
infection, cell lysates were immunoblotted with anti-active JNK, anti-
FLAG, or anti-actin antibody. Actin is shown as an internal standard.
WB, Western blot; IP, immunoprecipitation.
FIG. 5. Effect of JBD overexpression on glucose deprivation-
induced JNK1 activation. Cells were infected with either adenoviral
vectors containing FLAG-tagged JBD (Ad.FLAG-JBD) or Ad.EGFP at
an MOI of 100. After 48 h of infection, cells were exposed to glucose-free
medium for various times (10–120 min). Cell lysates containing equal
amounts of protein (20 g) were separated by SDS-PAGE and immu-
noblotted with anti-active JNK antibody, anti-FLAG antibody, or anti-
actin antibody. Actin was used to confirm the amount of protein loaded
in each lane. WB, Western blot.
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DISCUSSION
The goal of our studies was to examine whether ASK-SEK1-
JNK1 signaling is responsible for Daxx trafficking. Previous
studies have shown that Daxx, which contains two nuclear
localization signals, is mainly located in the nucleus of an
unstressed cell (13). It interacts with nuclear proteins such as
centrometric protein, Pax, and promyelocytic leukemia protein
(25). Our data show that Daxx relocalizes from the nucleus to
the cytoplasm during glucose deprivation and H2O2 treatment
(Figs. 3B and 6D). Overexpression of JBD, which inhibits glu-
cose deprivation-induced JNK1 activation, also suppresses the
relocalization of Daxx to the cytoplasm (Figs. 6D). Moreover,
overexpression of JBD prevents the glucose deprivation-in-
duced association of Daxx with ASK1 (Fig. 6A). These results
suggest that glucose deprivation-activated ASK1-SEK1-JNK1
play an important role in the relocalization of Daxx to the
were infected with Ad.HA-ASK1 at an MOI of 10, Ad.FLAG-Daxx at an
MOI of 10, and Ad.FLAG-JBD/Ad.EGFP at an MOI of 100. After 48 h of
incubation, cells were exposed to glucose-free medium for 1 h (A) or
H2O2 (500 M) (B) for 30 min. Lysates were immunoprecipitated with
anti-HA antibody and immunoblotted with anti-FLAG or anti-HA an-
tibody (upper panels). The presence of FLAG-Daxx, FLAG-JBD, or actin
in the lysates was verified by immunoblotting with anti-FLAG or anti-
actin antibody (lower panels). C, cells were co-infected with Ad.FLAG-
Daxx at an MOI of 10 and Ad.HA-ASK1 at an MOI of 10. After 48 h of
infection, cells were treated with SB203580 (10 M) for 30 min before
and during glucose deprivation for 1 h. Lysates were immunoprecipi-
tated with anti-HA antibody and immunoblotted with anti-FLAG or
anti-HA antibody (upper panels). The presence of FLAG-Daxx or actin
in the lysates was verified by immunoblotting with anti-FLAG or anti-
actin antibody (lower panels). Actin is shown as an internal standard.
D, cells were infected with Ad.His-Daxx alone (left panels), co-infected
with Ad.His-Daxx at an MOI of 10 and Ad.FLAG-JBD at an MOI of 100
(middle panels), or infected with Ad.His-Daxx at an MOI of 10 and
treated with SB203580 (10 M) 30 min before and during glucose
deprivation or H2O2 treatment (right panels). After 48 h of infection,
cells were exposed to either glucose-free medium for 1 h or H2O2 (500
M) for 30 min. The subcellular localization of Daxx was determined by
immunofluorescent staining with anti-His antibody. WB, Western blot;
IP, immunoprecipitation.
FIG. 6. Effect of JBD overexpression (A and B) or SB203580 (C) on the
interaction between ASK1 and Daxx in DU-145 cells. A and B, cells
FIG. 7. Effect of JBD overexpression on glucose deprivation-
induced Daxx phosphorylation. Du-145 cells were infected with
Ad.His-Daxx at an MOI of 10 and Ad.FLAG-JBD/Ad.EGFP at an MOI
of 100. After 48 h of infection, cells were pre-equilibrated in phosphate-
free medium for 3 h prior to the addition of 50 Ci/ml [32P]orthophos-
phate in phosphate and glucose-free medium for 1 h and lysed. Cell
lysates were divided into two portions. One portion was immunopre-
cipitated with anti-His antibody, and the immune complex was sepa-
rated by SDS-PAGE. The dried gel was visualized by autoradiography
(upper panel). The other portion was immunoblotted with anti-His,
anti-active-JNK, anti-FLAG, or anti-actin antibody (lower panels). Ac-
tin was used to confirm that similar amounts of proteins were loaded in
each lane. WB, Western blot; IP, immunoprecipitation.
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cytoplasm and its subsequent interaction with ASK1. Recent
studies also demonstrate that Daxx requires ASK1 for its cy-
toplasmic localization (13). Overexpression of ASK1 stimulates
the redistribution of Daxx to the cytoplasm (13). The relocal-
ization of Daxx is probably due to an elevated level of JNK1
activity (26). Our data show that Daxx was phosphorylated
during glucose deprivation, and its phosphorylation was medi-
ated through HIPK1 activation (Fig. 8). These results are con-
sistent with recent studies that show that HPIK modulates
Daxx relocalization and phosophorylation (24). Our data
clearly demonstrate that JNK1 activates HIPK1, which then
consequently phosphorylates Daxx during glucose deprivation.
Our studies also show that Daxx relocalization was inhibited
by inhibiting JNK1 activation by JBD overexpression (Figs. 5
and 6D). It is possible that Daxx phosphorylation is associated
with Daxx export from the nucleus. Recently, several research-
ers reported that yeast transcription factor, Yap1, a subfamily
of AP-1, which is a sensor of the redox state of the cell, is
activated by oxidative stress such as H2O2 (27, 28). Activated
Yap1 (oxidized form) leads to disulfide bond formation in the
C-terminal cysteine-rich region, which contains 3 conserved
cysteines and the nuclear export signal. Formation of an in-
tramolecular disulfide linkage leads to a conformational
change of Yap1 and consequently conceals the nuclear export
signal from the export receptor Crm1p/Xpo1p, resulting in the
localization of Yap1p to the nucleus. In contrast to Yap1p in
yeast, Daxx in mammalian cells could be exported to the cyto-
plasm during oxidative stress through an export receptor,
FIG. 8. Phosphorylation of Daxx is mediated by JNK1-HIPK1
during glucose deprivation. DU-145 cells were infected with Ad.His-
JNK1 at an MOI of 10. After 48 h of infection, cells were exposed to
glucose-free medium for 1 h and lysed. Cell lysates were divided into
two portions. One portion was immunoprecipitated with mouse anti-His
antibody. A, to examine whether the Daxx is a direct substrate of JNK1,
1 g of His-Daxx or GST-c-Jun was incubated with immunoprecipitated
His-JNK1 in kinase buffer containing 100 Ci/ml [-32P]ATP at 30 °C
for 1 h. B, to examine whether the HIPK1 is a direct substrate of JNK1,
0.5 g of GST-HIPK1 or 1 g of GST-c-Jun was incubated with immu-
noprecipitated His-JNK1 in kinase buffer containing 100 Ci/ml
[-32P]ATP at 30 °C for 1 h. C, to examine whether the Daxx is a
sequential substrate of HIPK1, 0.1 g of GST-HIPK1 was incubated
with immunoprecipitated His-JNK1 in kinase buffer containing 100 M
ATP at 30 °C for 30 min and subsequently with 1 g of His-Daxx with
100 Ci/ml [-32P]ATP at 30 °C for an additional 30 min. Phosphoryl-
ated proteins were resolved by SDS-PAGE and analyzed by autoradiog-
raphy (upper panel). The other portion was immunoblotted with anti-
active JNK or anti-His antibody (lower panels). WB, Western blot; IP,
immunoprecipitation.
FIG. 9. Role of serine 667 of Daxx in glucose deprivation-in-
duced Daxx relocalization. DU145 cells were transfected with
pFLAGCMV2-Daxx (wild type), pFLAGCMV2-Daxx (S667A), or
pFLAGCMV2-Daxx (S670A). After 48 h of transfection, cells were ex-
posed to glucose-free medium for 1 h. The subcellular localization of
Daxx was determined by immunofluorescent staining with anti-FLAG
antibody.
FIG. 10. Effect of JBD overexpression on the oligomerization
of ASK1 during glucose deprivation in DU-145 cells. Cells were
co-infected with Ad.HA-ASK1, Ad.Myc-ASK1, and Ad.FLAG-Daxx at an
MOI of 10 and then Ad.FLAG-JBD at an MOI of 100. After 48 h of
infection, cells were exposed to complete medium or glucose-free me-
dium for 1 h. Lysates were immunoprecipitated (IP) with anti-HA
antibody and immunoblotted with anti-Myc or anti-HA antibody (upper
panels). The presence of Myc-ASK1, FLAG-Daxx (aa 501–625), or
FLAG-JBD in the lysates was verified by immunoblotting with anti-
Myc or anti-FLAG antibody (lower panels). WB, Western blot.
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which is similar to Crm1p/Xpo1p in yeast. We postulate that
phosphorylation of Daxx results in conformational changes,
exposing the nuclear export signal, which would be recognized
by an export receptor. Interaction between the nuclear export
signal of Daxx and the export receptor may thus be the critical
step in redirecting nuclear Daxx to the cytoplasm. Obviously,
this model requires substantiation.
It is well known that the C-terminal 112 amino acids of Daxx
(aa 626–739) are necessary for Fas binding. However, prior to
our study, it was not clear which portion of Daxx is responsible
for ASK1 binding. Our data demonstrate that the ASK1 bind-
ing site of Daxx resides in the region of amino acids 501–625
(Fig. 3A). Interestingly, we observed that this deletion mutant
is mainly localized to the cytoplasm (Fig. 3B). Moreover, over-
expression of Daxx 501–625 promotes ASK1 oligomerization as
well as JNK1 activation, even in the presence of glucose (Figs.
4C and 10). These results are consistent with previous obser-
vations that Daxx 501–625 induces JNK activation as well as
apoptotic death (12). These results also suggest that the ASK1
binding site of Daxx plays a role in ASK1 oligomerization and
that oligomerization of ASK1 is sufficient for activation of the
ASK1-SEK1-JNK1 signal transduction pathway. This observa-
tion is supported by data from previous studies, which have
shown that TRAF2 enhances ASK1 homo-oligomerization and
consequently promotes ASK1 activation (11). Although we are
far from understanding how Daxx regulates ASK1 oligomeriza-
tion, we present the possible role of Daxx in the ASK1-SEK1-
JNK1-HIPK1 signal transduction pathway. We hypothesize
that activation of the ASK1-SEK1-JNK1-HIPK1 signal pro-
motes relocalization of Daxx, which stabilizes ASK1 oliogomer-
ization and maintains the activation of ASK-SEK1-JNK1 sig-
nal. If Daxx does not bind to ASK1, activated ASK1 may be
quickly inactivated through degradation. We believe that this
model will provide a framework for future studies.
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FIG. 11. A theoretical model for the
mechanism by which Daxx is in-
volved in glucose deprivation-in-
duced ASK1-SEK1-JNK1-HIPK1 sig-
nal transduction. This model illustrates
that Daxx is phosphorylated and relocal-
ized from the nucleus to the cytosol
through the ASK1-SEK1-JNK1-HIPK1
signal transduction pathway during glu-
cose deprivation. Daxx binds to ASK1 and
may stabilize the form of ASK1 oligomer.
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